# Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women

> **NCT04354441** · PHASE2 · WITHDRAWN · sponsor: **Sir Mortimer B. Davis - Jewish General Hospital**

## Conditions studied

- COVID-19
- SARS-CoV-2
- Pregnant Women
- Hydroxychloroquine

## Interventions

- **DRUG:** hydroxychloroquine sulfate 200 MG
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04354441
- **Lead sponsor:** Sir Mortimer B. Davis - Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not started
- **Last updated:** 2020-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04354441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04354441, "Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04354441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*